AMBER FRITZLER: Open Payments
NPI 1235770819 · SAGINAW, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$815 in 39 payments from 9 companies in 2025. Trend: 2023 $2,164 · 2024 $613 · 2025 $815
Food & beverage: $705Education: $109
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 15 | $298 |
| Teva Pharmaceuticals USA, Inc. | 6 | $175 |
| Lundbeck LLC | 7 | $147 |
| Axsome Therapeutics, Inc. | 3 | $69 |
| E.R. Squibb & Sons, L.L.C. | 4 | $60 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: ARISTADA, REXULTI, Auvelity, COBENFY, FANAPT, INVEGA SUSTENNA, TRINTELLIX.
Industry payments across MI — which companies pay providers there.
